Carter's (CRI) Tops Q4 EPS by 25c, Offers Guidance

Carter's (NYSE: CRI) reported Q4 EPS of $2.31, $0.25 better than the analyst estimate of $2.06. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.03 billion.

GUIDANCE:

Carter's sees Q1 2022 EPS of $1.25-$1.35, versus the consensus of $1.54. Carter's sees Q1 2022 revenue of $740-750 billion, versus the consensus of $804 billion.

For fiscal 2022, the Company projects:

• Net sales increase of approximately 2% to 3%, with growth in all segments;
• Adjusted operating income increase of approximately 4% to 6% (compared to adjusted operating income of $500.8 million in fiscal 2021); and
• Adjusted diluted earnings per share increase of approximately 12% to 14% (compared to adjusted diluted earnings per share of $7.87 in fiscal 2021).

For earnings history and earnings-related data on Carter's (CRI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance